We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
-23.97%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.26B
AUM Growth
-$359M
(-22%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
10.35%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
929
New
226
Increased
255
Reduced
141
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$27.2M |
| 2 |
EOG Resources
EOG
|
+$17.7M |
| 3 |
Lyft
LYFT
|
+$10.9M |
| 4 |
GE Aerospace
GE
|
+$10.5M |
| 5 |
Apple
AAPL
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.8M |
| 2 |
SMAR
Smartsheet Inc.
SMAR
|
+$10.2M |
| 3 |
ServiceNow
NOW
|
+$9.31M |
| 4 |
Hilton Worldwide
HLT
|
+$9.17M |
| 5 |
Paylocity
PCTY
|
+$8.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.51% |
| 2 | Technology | 16.97% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.47% |
| 5 | Financials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Metallus
MTUS
$826M
| $126K | 0.01% |
38,927
+10,285
| +36% | +$57.6K |
|
602
Vitamin Cottage Natural Grocers
NGVC
$741M
| $124K | 0.01% |
14,520
+220
| +2% | +$1.89K |
|
|
BDSI
603
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $123K | 0.01% |
32,500
+8,991
| +38% | +$44.2K |
|
604
Dana Inc
DAN
$2.91B
| $117K | 0.01% |
+14,968
| New | +$207K |
|
605
QuinStreet
QNST
$890M
| $117K | 0.01% |
+14,500
| New | +$179K |
|
606
Spok Holdings
SPOK
$225M
| $117K | 0.01% |
10,967
-2,500
| -19% | -$26.9K |
|
607
Amalgamated Financial
AMAL
$1.48B
| $116K | 0.01% |
+10,700
| New | +$171K |
|
608
Gates Industrial Corporation Ltd.
GTES
$6.53B
| $115K | 0.01% |
+15,567
| New | +$173K |
|
|
GOGL
609
DELISTED
Golden Ocean Group
GOGL
| $113K | 0.01% |
36,200
| – | – |
|
|
NPKI
610
NPK International
NPKI
$1.05B
| $113K | 0.01% |
125,600
+57,300
| +84% | +$215K |
|
611
Gyre Therapeutics
GYRE
$648M
| $105K | 0.01% |
3,193
+1,633
| +105% | +$75K |
|
612
Daktronics
DAKT
$941M
| $104K | 0.01% |
21,021
+4,663
| +29% | +$25.9K |
|
613
Old Second Bancorp
OSBC
$1.29B
| $104K | 0.01% |
15,054
+4,702
| +45% | +$51.7K |
|
|
ARA
614
DELISTED
American Renal Associates Holdings, Inc
ARA
| $103K | 0.01% |
+15,627
| New | +$136K |
|
|
CBIO
615
Crescent Biopharma
CBIO
$555M
| $96K | 0.01% |
419
-2
| -0.5% | -$764 |
|
616
A10 Networks
ATEN
$2.16B
| $94K | 0.01% |
+15,207
| New | +$97.2K |
|
617
Cyclerion Therapeutics
CYCN
$15.2M
| $92K | 0.01% |
+1,733
| New | +$124K |
|
|
ONDK
618
DELISTED
On Deck Capital, Inc.
ONDK
| $92K | 0.01% |
60,000
| – | – |
|
619
Alpha and Omega Semiconductor
AOSL
$931M
| $83K | 0.01% |
12,946
+1,663
| +15% | +$18.1K |
|
620
TransAlta
TAC
$4.06B
| $82K | 0.01% |
+15,744
| New | +$107K |
|
|
TCS
621
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $80K | 0.01% |
2,266
| – | – |
|
622
Newmark Group
NMRK
$2.68B
| $76K | 0.01% |
+17,800
| New | +$175K |
|
623
IDT Corp
IDT
$1.64B
| $67K | 0.01% |
12,290
-600
| -5% | -$4.29K |
|
624
Citizens
CIA
$246M
| $65K | 0.01% |
+10,000
| New | +$61.8K |
|
625
Navigator Holdings
NVGS
$1.37B
| $65K | 0.01% |
14,500
-1,961
| -12% | -$19.6K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q1 2020 Portfolio in Review
As of Q1 2020, PDT Partners held 929 positions worth $1.26B, down 22% from $1.62B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
PDT Partners deployed $131M of net new capital in Q1 2020, opening 226 new positions and adding to 255 existing holdings. Its largest new stake was GE Aerospace: 196,102 shares worth $7.76M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Paylocity, an estimated $8.99M trimmed.
- PDT Partners's largest Q1 2020 buy was GE Aerospace: 196,102 shares worth $7.76M.
- PDT Partners added most to AbbVie in Q1 2020, an estimated $27.2M increase.
- PDT Partners's biggest Q1 2020 reduction was Paylocity, cutting an estimated $8.99M.
- PDT Partners fully exited Bristol-Myers Squibb in Q1 2020, selling an estimated $10.8M.
- PDT Partners's ten largest holdings make up 15% of its $1.26B portfolio in Q1 2020.
- PDT Partners opened 226 new positions and closed 293 in Q1 2020.
- PDT Partners's portfolio value fell 22% quarter-over-quarter to $1.26B.
Based on PDT Partners's 13F filing for Q1 2020, filed 15 May 2020.